Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
CD8-HF248 | Human | FITC-Labeled Human CD98 Protein, His Tag | ![]() |
![]() ![]() |
|
CD8-H5247 | Human | Human CD98 Protein, His Tag (MALS verified) | ![]() |
![]() ![]() |
Please contact us via TechSupport@acrobiosystems.com if you have any question on this product.
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
JPH-203 | JPH-203; KYT-0353; JPH-203SBECD | Phase 2 Clinical | J-Pharma | Biliary Tract Neoplasms | Details |
R-OKY-034F | R-OKY-034F | Phase 2 Clinical | Osaka University, Japan Agency For Medical Research And Development | Pancreatic Neoplasms | Details |
[18F]AA-7 | [18F]AA-7 | Clinical | Osaka City University, Institute Physical Chemical Research (Riken), Nagase Medicals | Glioma | Details |
QBS-10072S | QBS-10072S | Phase 1 Clinical | Novotech (Australia) Pty Ltd | Sarcoma; Uterine Cervical Neoplasms; Tongue Neoplasms; Melanoma; Neoplasm Metastasis; Lung Neoplasms; Brain metastases; Thymoma; Central Nervous System Diseases; Urologic Neoplasms; Colorectal Neoplasms; Astrocytoma; Prostatic Neoplasms; Liver Neoplasms; Brain Neoplasms; Breast Neoplasms; Cholangiocarcinoma; Urinary Bladder Neoplasms; Mesothelioma; Pancreatic Neoplasms; Stomach Neoplasms; Esophageal Neoplasms; Kidney Neoplasms; Head and Neck Neoplasms; Ovarian Neoplasms | Details |
NBQ72S | NBQ72S | Phase 1 Clinical | Brain Neoplasms | Details | |
TLX-101 | 131I-IPA; 131I-ACD-101 | Phase 2 Clinical | Telix Pharmaceuticals | Breast Neoplasms | Details |
TLX101-CDx | TLX-101-CDx; 18F-FET | Phase 2 Clinical | Telix Pharmaceuticals Ltd | Breast Neoplasms | Details |
This web search service is supported by Google Inc.